Sanofi SA (SASY.PA)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|67||2015||Independent Chairman of the Board|
|62||2015||Chairman of the Executive Committee, Chief Executive Officer, Director|
|53||2018||Chief Financial Officer, Executive Vice President, Member of the Executive Committee|
|59||2014||Executive Vice President - Legal Affairs and General Counsel, Member of the Executive Committee|
|54||2009||Executive Vice President - Human Resources, Member of the Executive Committee|
- UPDATE 1-Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva
- UPDATE 2-Minnesota accuses insulin makers of deceptive drug pricing
- Minnesota accuses insulin makers of deceptive drug pricing
- French and Benelux stocks-Factors to watch on Oct 16
- Sanofi, Regeneron say late-stage Dupixent trials show positive results